Q3 FY2026 · ended Sep 30, 2026 · Revenue $80.67M, +12.2% YoY · Filed Nov 4, 2026
Viemed Healthcare, Inc. (VMD) files with the SEC under industry code 8090, Services-Misc Health & Allied Services, NEC. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $80.7 million and net income of $4.6 million. Free cash flow was $2.9 million. As of Sep 30, 2026 it held $9.7 million in cash and investments and $9.3 million in total debt.
Company profile
- Industry
- Services-Misc Health & Allied Services, NEC (SIC 8090)
- Listed as
- VMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Lafayette, LA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1729149
Other Services-Misc Health & Allied Services, NEC companies
- Fresenius Medical Care AG FMS
- Davita Inc. DVA
- Sotera Health Co SHC
- Progyny, Inc. PGNY
- agilon health, inc. AGL
- Charming Medical Ltd MCTA
- Park Dental Partners, Inc. PARK
- Marpai, Inc. MRAI
All 15 Services-Misc Health & Allied Services, NEC companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $80.7M | $78.1M | $75.4M | $76.2M | $71.9M |
| Operating income | $7.0M | $4.5M | $4.3M | $8.4M | $5.6M |
| Net income | $4.6M | $2.8M | $2.6M | $5.6M | $3.5M |
| Diluted EPS | $0.11 | $0.07 | $0.06 | $0.14 | $0.09 |
| Operating cash flow | $11.5M | $15.9M | $8.1M | $18.4M | $18.4M |
| Free cash flow | $2.9M | $7.4M | $1.4M | $9.7M | $10.7M |
| Total assets | $207.6M | $204.2M | $197.4M | $199.2M | $202.4M |
| Total liabilities | $55.6M | $58.3M | $51.6M | $55.6M | $66.9M |
| Stockholders' equity | $150.1M | $144.0M | $143.9M | $141.5M | $133.6M |
| Cash and investments | $9.7M | $10.7M | $9.8M | $13.5M | $11.1M |
| Total debt | $9.3M | $11.6M | $12.4M | $15.9M | $24.7M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 3, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 4, 2026 | Jun 4, 2026 |
All 419 Viemed Healthcare, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.